Lawrenceville, NJ, United States of America

Peng Guo

This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peng Guo. Retrieved from https://idiyas.com/inventor/peng-guo-u4frxjs3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Peng Guo

Introduction

Peng Guo is an accomplished inventor based in Lawrenceville, NJ (US). He has made significant contributions to the field of chemistry, particularly in the development of novel processes for the production of amines. His work has implications for various pharmaceutical applications.

Latest Patents

Peng Guo holds a patent for a process titled "Reductive alkylation of secondary amines with hydrosilane." This innovative method involves the reductive alkylation of secondary amines using hydrosilane and a Lewis acid to produce tertiary amines. The process has potential applications in the preparation of imidazole-containing benzodiazepines, which are known inhibitors of farnesyl protein transferase.

Career Highlights

Peng Guo is currently employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His role at the company allows him to apply his expertise in chemistry to develop new therapeutic solutions.

Collaborations

Throughout his career, Peng has collaborated with notable colleagues, including Bang-Chi Chen and Joseph E. Sundeen. These collaborations have further enhanced his research and development efforts in the pharmaceutical industry.

Conclusion

Peng Guo's innovative work in the field of chemistry, particularly in the area of amine production, showcases his valuable contributions to the pharmaceutical industry. His patent and collaborations highlight his commitment to advancing scientific knowledge and developing new therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…